FFO
BIO icon

Fortitude Family Office’s Bio-Rad Laboratories Class A BIO Stock Holding History

Fortitude Family Office’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.8K Buy
28
+5
+22% +$1.44K ﹤0.01% 745
2025
Q4 		$6.97K Buy
23
+1
+5% +$312 ﹤0.01% 698
2025
Q3 		$6.17K Buy
22
+10
+83% +$2.72K ﹤0.01% 741
2025
Q2 		$2.9K Sell
12
-4
-25% -$946 ﹤0.01% 1026
2025
Q1 		$3.9K Sell
16
-2
-11% -$602 ﹤0.01% 791
2024
Q4 		$5.91K Sell
18
-2
-10% -$679 ﹤0.01% 788
2024
Q3 		$6.69K Buy
20
+4
+25% +$1.27K ﹤0.01% 686
2024
Q2 		$4.37K Hold
16
– – ﹤0.01% 644
2024
Q1 		$5.53K Hold
16
– – ﹤0.01% 558
2023
Q4 		$5.17K Buy
+16
New +$5.01K ﹤0.01% 614

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return